SCHEMBL7474701

SCHEMBL7474701

CCC(=O)c1c(CC)n(Cc2ccccc2Cl)c2cc(C(=O)OC)ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.45
TP53 P04637 2/20 0.45
DPP4 P27487 2/20 0.43
LMNA P02545 2/20 0.43
S1PR3 Q99500 1/20 0.42
KDM4E B2RXH2 3/20 0.41
TNF P01375 1/20 0.41
NOD2 Q9HC29 1/20 0.41
NOD1 Q9Y239 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
MAPK1 P28482 2/20 0.41
POLB P06746 1/20 0.41
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HPGD P15428 1/20 0.40
PLA2G2A P14555 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419376 0.92 MAPT (0.43) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7419090 0.91 L3MBTL1 (0.47) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7468891 0.89 MAPT (0.44) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7420991 0.89 L3MBTL1 (0.49) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7470623 0.89 SLC22A12 (0.45) MAPTTP53DPP4KDM4ETNF
SCHEMBL7420966 0.88 ALOX5AP (0.44) MAPTTP53DPP4LMNAKDM4E
SCHEMBL7426911 0.87 MAPT (0.47) MAPTTP53DPP4LMNAKDM4E
SCHEMBL7415615 0.85 MAPT (0.43) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7701998 0.84 MAPT (0.45) MAPTTP53DPP4LMNAKDM4E
SCHEMBL7473116 0.84 MAPT (0.48) MAPTTP53DPP4LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed